Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4929097 in Advanced Platinum Resistant Ovarian Cancer
NCT01175343Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of RO4929097 in ovarian epithelial cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started Jul 2010; status: completed.
02
Drugs
RO4929097
03
Conditions
ovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01175343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175343.